Cargando…
Personalized medicine with biologics for severe type 2 asthma: current status and future prospects
Asthma affects more than 300 million people worldwide and poses a large socioeconomic burden, particularly in the 5% to 10% of severe asthmatics. So far, each entry of new biologics in clinical trials has led to high expectations for treating all severe asthma forms, but the outcome has only been su...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800381/ https://www.ncbi.nlm.nih.gov/pubmed/29035619 http://dx.doi.org/10.1080/19420862.2017.1392425 |